BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5571349)

  • 1. Acute toxicity of propoxyphene salts.
    Emmerson JL; Gibson WR; Anderson RC
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):445-51. PubMed ID: 5571349
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term toxicity of propoxyphene salts in rats and dogs.
    Emmerson JL; Gibson WR; Harris PN; Todd GC; Pierce EC; Anderson RC
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):452-70. PubMed ID: 5571350
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case 1--equimolar doses.
    Rodda BE; Scholz NE; Gruber CM; Wolen RL
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):554-62. PubMed ID: 4937002
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentration of propoxyphene in human plasma following repeated oral doses.
    Wolen RL; Gruber CM; Kiplinger GF; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):493-7. PubMed ID: 5571352
    [No Abstract]   [Full Text] [Related]  

  • 5. The concentration of propoxyphene in the plasma and analgesia scores in postpartum patients.
    Wolen RL; Gruber CM; Baptisti A; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):498-503. PubMed ID: 5106308
    [No Abstract]   [Full Text] [Related]  

  • 6. Reproduction and teratology studies on propoxyphene napsylate.
    Emmerson JL; Owen NV; Koenig GR; Markham JK; Anderson RC
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):471-9. PubMed ID: 5571351
    [No Abstract]   [Full Text] [Related]  

  • 7. Analgesia scores as timed responses following oral administration of propoxyphene to postpartum patients.
    Gruber CM; Wolen RL; Baptisti A
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):504-11. PubMed ID: 4936998
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute toxicity study of buspirone hydrochloride in mice, rats and dogs].
    Kadota T; Kawano S; Chikazawa H; Kondoh H; Kuroyanagi K; Ohta S; Ishikawa K; Kai S; Kohmura H; Takahashi N
    J Toxicol Sci; 1990 Apr; 15 Suppl 1():1-14. PubMed ID: 2376867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits.
    Lund-Jacobsen H
    Acta Pharmacol Toxicol (Copenh); 1978 Mar; 42(3):171-8. PubMed ID: 580345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of propoxyphene abuse.
    Tennant FS
    Arch Intern Med; 1973 Aug; 132(2):191-4. PubMed ID: 4719546
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of propoxyphene and salicylate concentrations in human plasma following the administration of propoxyphene napsylate and aspirin.
    Nash JF; Scholz NE; Maxwell SB
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):537-45. PubMed ID: 5571353
    [No Abstract]   [Full Text] [Related]  

  • 12. Near fatal reaction to ingestion of the hallucinogenic drug MDA.
    Richards KC; Borgstedt HH
    JAMA; 1971 Dec; 218(12):1826-7. PubMed ID: 5171448
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of the effects of chronic administration of propoxyphene salts to normal volunteers.
    Kiplinger GF; Gruber CM; Pierce EC
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):528-36. PubMed ID: 4937001
    [No Abstract]   [Full Text] [Related]  

  • 14. The effectiveness and side-effect liability of propoxyphene hydrochloride and propoxyphene napsylate in patients with postpartum uterine cramping.
    Baptisti A; Gruber CM; Santos EL
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):519-27. PubMed ID: 4937000
    [No Abstract]   [Full Text] [Related]  

  • 15. Dependence and central nervous system toxicity associated with the use of propoxyphene hydrochloride.
    Mattson RH; Weisman GK; Levy LL
    Trans Am Neurol Assoc; 1969; 94():299-301. PubMed ID: 5374468
    [No Abstract]   [Full Text] [Related]  

  • 16. Relief of postpartum uterine cramping with propoxyphene and aspirin.
    Gruber CM; Baptisti A; Kiplinger GF
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):546-53. PubMed ID: 5106309
    [No Abstract]   [Full Text] [Related]  

  • 17. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.
    Wolen RL; Gruber CM; Kiplinger GF; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):480-92. PubMed ID: 4936997
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulfolane-induced convulsions in rodents.
    Andersen ME; Jones RA; Kurlansik L; Mehl RG; Jenkins LJ
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):571-80. PubMed ID: 825938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on acute toxicity of desacetylcephalothin (author's transl)].
    Kuramoto M; Ishimura Y; Morimoto J; Lee S; Katori T
    Jpn J Antibiot; 1975 Feb; 28(1):81-4. PubMed ID: 1127833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.